These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31429520)

  • 1. A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients.
    Tang J; Ren J; Cui Q; Zhang D; Kong D; Liao X; Lu M; Gong Y; Wu G
    J Cell Mol Med; 2019 Oct; 23(10):6775-6784. PubMed ID: 31429520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy.
    Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
    J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.
    Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
    J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.
    Tang J; Cui Q; Zhang D; Liao X; Zhu J; Wu G
    J Cell Mol Med; 2019 Aug; 23(8):4980-4990. PubMed ID: 31124293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
    Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
    Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
    Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
    J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated mRNA-lncRNA signature for relapse prediction in laryngeal cancer.
    Xiang Y; Li C; Liao Y; Wu J
    J Cell Biochem; 2019 Sep; 120(9):15883-15890. PubMed ID: 31062433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
    Liu D
    Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy.
    Sun M; Liu X; Xia L; Chen Y; Kuang L; Gu X; Li T
    Biochem Pharmacol; 2021 Jul; 189():114285. PubMed ID: 33069665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
    Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
    Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune-related prognostic signature for predicting breast cancer recurrence.
    Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
    Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Ten-lncRNA Signature Prognostic Model for Breast Cancer Survival: A Study with the TCGA Database.
    Zhou W; Pang Y; Yao Y; Qiao H
    Anal Cell Pathol (Amst); 2020; 2020():6827057. PubMed ID: 32908814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer.
    Li Z; Zheng J; Feng Y; Li Y; Liang Y; Liu Y; Wang X; Yang Q
    Cancer Med; 2021 Nov; 10(21):7877-7892. PubMed ID: 34581026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.
    Wang K; Li J; Xiong YF; Zeng Z; Zhang X; Li HY
    Sci Rep; 2018 Feb; 8(1):3179. PubMed ID: 29453409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.